Rockwell Medical Correlations
RMTI Stock | USD 1.17 0.05 4.46% |
The current 90-days correlation between Rockwell Medical and Lifecore Biomedical is 0.41 (i.e., Very weak diversification). The correlation of Rockwell Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Rockwell Medical Correlation With Market
Very weak diversification
The correlation between Rockwell Medical and DJI is 0.46 (i.e., Very weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Rockwell Medical and DJI in the same portfolio, assuming nothing else is changed.
Moving together with Rockwell Stock
0.7 | BIOA | BioAge Labs, | PairCorr |
0.75 | A | Agilent Technologies Earnings Call This Week | PairCorr |
0.63 | DH | Definitive Healthcare | PairCorr |
0.9 | EQ | Equillium | PairCorr |
0.71 | LH | Laboratory | PairCorr |
0.96 | DMAC | DiaMedica Therapeutics | PairCorr |
0.81 | VANI | Vivani Medical Earnings Call This Week | PairCorr |
0.81 | DNLI | Denali Therapeutics | PairCorr |
0.71 | DNTH | Dianthus Therapeutics | PairCorr |
0.85 | DOCS | Doximity | PairCorr |
0.89 | VCEL | Vericel Corp Ord | PairCorr |
0.75 | VCYT | Veracyte | PairCorr |
0.88 | VERV | Verve Therapeutics | PairCorr |
0.89 | VERA | Vera Therapeutics Earnings Call This Week | PairCorr |
0.7 | DRMA | Dermata Therapeutics | PairCorr |
0.71 | DRUG | Bright Minds Biosciences | PairCorr |
0.75 | DRTS | Alpha Tau Medical | PairCorr |
0.74 | VIGL | Vigil Neuroscience | PairCorr |
0.63 | DVAX | Dynavax Technologies | PairCorr |
Moving against Rockwell Stock
0.84 | CI | Cigna Corp | PairCorr |
0.61 | ZOMDF | Zomedica Corp | PairCorr |
0.49 | LNTH | Lantheus Holdings Sell-off Trend | PairCorr |
0.4 | YCBD-PA | cbdMD Inc Earnings Call This Week | PairCorr |
0.33 | SRZNW | Surrozen Warrant | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Rockwell Stock performing well and Rockwell Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Rockwell Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
LFCR | 2.75 | 0.57 | 0.08 | 0.17 | 5.01 | 6.01 | 27.76 | |||
KMDA | 2.07 | 0.01 | 0.00 | (0.10) | 0.00 | 4.69 | 14.70 | |||
ITCI | 0.17 | 0.09 | 2.37 | (16.60) | 0.00 | 0.50 | 2.48 | |||
AGRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
EGRX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RGC | 19.92 | 9.46 | 0.89 | (4.53) | 8.36 | 62.58 | 265.55 | |||
PROC | 9.81 | 2.78 | 0.13 | 97.91 | 9.76 | 16.00 | 183.01 | |||
CPIX | 7.22 | 1.72 | 0.29 | (18.97) | 5.67 | 17.70 | 98.19 | |||
IXHL | 6.89 | (3.20) | 0.00 | 4.79 | 0.00 | 6.78 | 146.84 | |||
AQST | 3.62 | 0.13 | 0.00 | (0.01) | 0.00 | 8.36 | 23.68 |
Rockwell Medical Corporate Management
Megan Timmins | Chief VP | Profile | |
David Kull | Principal Accounting Officer | Profile | |
Jason Finkelstein | Investor Representative | Profile | |
Nicholas Fanslau | Controller Officer | Profile | |
Marc MD | Chief Officer | Profile |